Background: Orexins A and B are neuropeptides that regulate feeding behavior and are localized exclusively in neurons within and around the lateral hypothalamic area. Intracerebroventricular injection of orexin A stimulates food consumption in rats. Plasma concentrations of orexins may reflect nutritional states and may have clinical significance in patients on hemodialysis. In this study, we investigated the relationship between plasma orexin concentrations and nutritional states in patients on hemodialysis. Method: We measured plasma orexin concentrations in patients on hemodialysis (HD group, n = 67), patients with IgA nephropathy (n = 10), patients with diabetes mellitus (n = 11) and healthy controls (n = 10). We examined the relationships between plasma orexin concentrations and nutritional indices. Results: Plasma orexin A concentrations were significantly higher in the HD group than in the control group and showed a significant correlation with serum creatinine. In all subjects, there was a positive correlation between the plasma orexin A concentration and the serum creatinine concentration, but there were no correlations between these concentrations in each group. In the HD group, plasma orexin A concentrations had a significant positive correlation with the serum albumin concentration and percent creatinine generation rate (%CGR). Multiple regression analysis demonstrated that %CGR was the only independent factor associated with plasma orexin A concentrations. Conclusion: Plasma orexin A concentrations are increased in patients on hemodialysis. It is possible that the kidney plays a major role in the clearance of orexins. The plasma orexin A concentration is significantly correlated with %CGR, and it may be able to be used as a clinical marker of the nutritional state in patients on hemodialysis.

Keywords:
Orexin, Hemodialysis, Nutritional state, Creatinine generation rate
1.
Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M: Orexins and orexin receptors. A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92:573–585.
2.
Malendowicz LK, Tortorella C, Nussdorfer GG: Orexins stimulate corticosterone secretion of rat adrenocortical cells, through the activation of the adenylate cyclase-dependent signaling cascade. J Steroid Biochem Mol Biol 1999;70:185–188.
3.
Nowak KW, Mackowiak P, Switonska MM, Fabis M, Malendowicz LK: Acute orexin effects on insulin secretion in the rat: In vivo and in vitro studies. Life Sci 2000;66:449–454.
4.
Nambu T, Sakurai T, Mizukami K, Hosoya Y, Yanagisawa M, Goto K: Distribution of orexin neurons in the adult rat brain. Brain Res 1999;827:243–260.
5.
Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS: Neurons containing hypocretin (orexin) project to multiple neural systems. J Neurosci 1998;18:9996–10015.
6.
Omura M, Iizuka T, Ishizuka T, Sakurai S, Nishikawa T, Iida S, Nakajima Y: Study of plasma orexin levels (abstract; in Japanese). J Jpn Soc Study Obes 1999;5(suppl):160.
7.
Shinzato T, Nakai S, Miwa M, Iwayama N, Takai I, Matsumoto Y, Morita H, Maeda K: New method to calculate creatinine generation rate using pre- and postdialysis creatinine concentrations. Artif Organs 1997;21:864–872.
8.
Oishi K, Nagake Y, Yamasaki H, Hukuda S, Icikawa H, Ota K, Makino H: The significance of serum homocysteine levels in diabetic patients on haemodialysis. Nephrol Dial Transplant 2000;15:851–855.
9.
Kastin AJ, Pan W, Maness LM, Banks WA: Peptides crossing the blood brain barrier: Some unusual observations. Brain Res 1999;848:96–100.
10.
Kastin AJ, Akerstrom V: Orexin A but not B enters brain from blood by simple diffusion. J Pharmacol Exp Ther 1999;289:219–223.
11.
Sweet DC, Levine AS, Billington CJ, Kotz CM: Feeding response to central orexins. Brain Res 1999;821:535–538.
12.
Kunii K, Yamanaka A, Nambu T, Matsuzaki I, Goto K, Sakurai T: Orexins/hypocretins regulate drinking behaviour. Brain Res 1999;842:256–271.
13.
Ida T, Nakahara K, Katayama T, Murakami N, Nakazato M: Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Res 1999;821:526–529.
14.
Takahashi N, Okumura T, Yamada H, Kohgo Y: Stimulation of gastric acid secretion by centrally administered orexin-A in conscious rats. Biochem Biophys Res Commun 1999;254:623.
15.
Iseki K, Kawazoe N, Fukiyama K: Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 1993;44:115–119.
16.
Nakai S, Shinzato T, Miwa M, Iwayama N, Matsumoto Y, Takai I, Wakai K, Maeda K: Predialysis serum albumin concentration and creatinine generation rate do not reflect the same pathophysiological status. Clin Exp Nephrol 1998;2:44–49.
17.
Japanese Society for Dialysis Therapy: An overview of regular dialysis treatment in Japan, Japanese Society for Dialysis Therapy, Tokyo, 1999, 10986–10987.
18.
Rodriguez-Carmona A, Perez Fontan M, Cordido F, Garcia Falcon T, Garcia-Buela J: Hyperleptinemia is not correlated with markers of protein malnutrition in chronic renal failure. A cross-sectional study in predialysis, peritoneal dialysis and hemodialysis patients. Nephron 2000;86:274–280.
19.
Nakazono H, Nagake Y, Ichikawa H, Makino H: Serum leptin concentrations in patients on hemodialysis. Nephron 1998;80:35–40.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.